- Home
- TNGX vs PMTS Comparison
TNGX vs PMTS Comparison
Compare TNGX & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- PMTS
- Stock Information
- Founded
- TNGX 2014
- PMTS 2007
- Country
- TNGX United States
- PMTS United States
- Employees
- TNGX N/A
- PMTS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- PMTS Finance Companies
- Sector
- TNGX Health Care
- PMTS Finance
- Exchange
- TNGX Nasdaq
- PMTS Nasdaq
- Market Cap
- TNGX 317.4M
- PMTS 316.9M
- IPO Year
- TNGX N/A
- PMTS 2015
- Fundamental
- Price
- TNGX $1.76
- PMTS $29.40
- Analyst Decision
- TNGX Strong Buy
- PMTS Strong Buy
- Analyst Count
- TNGX 7
- PMTS 4
- Target Price
- TNGX $12.33
- PMTS $37.25
- AVG Volume (30 Days)
- TNGX 801.9K
- PMTS 36.7K
- Earning Date
- TNGX 05-07-2025
- PMTS 03-04-2025
- Dividend Yield
- TNGX N/A
- PMTS N/A
- EPS Growth
- TNGX N/A
- PMTS N/A
- EPS
- TNGX N/A
- PMTS 1.64
- Revenue
- TNGX $42,069,000.00
- PMTS $480,601,000.00
- Revenue This Year
- TNGX N/A
- PMTS $8.62
- Revenue Next Year
- TNGX N/A
- PMTS $7.15
- P/E Ratio
- TNGX N/A
- PMTS $17.86
- Revenue Growth
- TNGX 15.17
- PMTS 8.11
- 52 Week Low
- TNGX $1.71
- PMTS $15.21
- 52 Week High
- TNGX $12.02
- PMTS $35.19
- Technical
- Relative Strength Index (RSI)
- TNGX 33.97
- PMTS 49.90
- Support Level
- TNGX $1.80
- PMTS $27.90
- Resistance Level
- TNGX $2.04
- PMTS $29.69
- Average True Range (ATR)
- TNGX 0.18
- PMTS 1.85
- MACD
- TNGX 0.01
- PMTS 0.00
- Stochastic Oscillator
- TNGX 20.19
- PMTS 34.93
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.